Many of the highest-value medicines now depend on temperature control. Insulin, vaccines, biologics and cell and gene therapies all lose potency when they leave their approved range, often without any visible sign. For distributors and buyers, a failed cold chain means scrapped stock, replacement shipments and, in the worst case, compromised product reaching a patient.
Estimates of the cost vary. An IQVIA Institute analysis, quoted in a 2019 industry survey, put annual biopharma losses from temperature-controlled logistics failures at about 35 billion US dollars, a figure that includes lost product, replacement, wasted logistics costs and root-cause investigations. The World Health Organization has long cited vaccine wastage of up to 50 percent in some settings, although that figure dates back to a 2005 paper and should be read as a historical estimate rather than a current average.
The more useful question for a business is which technologies have evidence behind them. This article reviews seven developments, from connected sensors to drones, and is clear about what each study did and did not show.
1. Continuous remote temperature monitoring
Manual temperature checks capture only moments in time. Connected loggers and sensors record continuously and send alerts the moment a unit drifts out of range.
The best field evidence comes from a pilot in Kenya, published in Global Health: Science and Practice in 2019. Remote temperature monitoring and data-review teams were introduced across 36 sites. Time spent in the correct temperature range rose from 83.9 percent to 90.9 percent, and time spent too cold fell from 6.5 percent to 1.5 percent. The authors credited SMS alarms, which prompted faster responses, and managers’ ability to spot recurring problems.
Two cautions. This was a vaccine programme in Kenya, not a commercial distribution network, and the benefit came from combining the technology with people reviewing the data. Sensor placement also matters. A hospital simulation of a power outage found that a refrigerator’s fixed probe registered a breach after 12.5 minutes, while loggers on the shelf and inside a box took 23 to 26 minutes, but those product-level loggers then took much longer to return to range once power was restored (70 to 89 minutes against 17.5 minutes). It was a small, exploratory study of one refrigerator type, but it shows why measuring the air alone can mislead.
2. Drone delivery for the last mile
The last leg of a journey is often the least controlled. Drones shorten it, especially where roads are poor.
A study in The Lancet Global Health (2022) examined Rwanda’s drone programme for blood products, run with the company Zipline. Across 12,733 orders delivered to 20 health facilities between March 2017 and December 2019, mean drone delivery took 49.6 minutes, about 79 minutes faster than estimated road delivery. After the programme began, blood unit expirations at the facilities fell by 7.1 units a month, which the authors translated into a 67 percent reduction at 12 months.
This is real evidence that faster, on-demand resupply can cut wastage, but it concerns blood products in one country. The authors themselves say further studies are needed on cost-effectiveness and on other pharmaceutical and health supplies. Regulation, weather limits and cost mean drones suit specific routes, not whole networks.
3. Solar direct-drive refrigeration
Where mains power fails, a cold chain can fail with it. Solar direct-drive (SDD) refrigerators run a compressor straight from solar panels and store cold in water or phase-change material rather than storing electricity in batteries.
WHO recommends solar refrigerators for areas with less than four hours of electricity a day, while Gavi recommends them for locations with fewer than eight hours of power a day or outages longer than 48 hours. Equipment purchased through these programmes must meet WHO’s performance, quality and safety (PQS) prequalification standards. In Lebanon, UNICEF and the health ministry installed more than 1,000 SDD units across over 800 health facilities to protect vaccines during an electricity crisis. A modelling study for Mozambique found that solar refrigerators can provide more vaccine doses at lower cost per dose than electric ones, though purchase price, lifetime and maintenance are important variables.
4. Controlled temperature chain (CTC)
Not every improvement involves more refrigeration. WHO’s controlled temperature chain allows certain vaccines to be kept above the standard 2 to 8 degrees Celsius for a limited period under monitored conditions. To qualify, a vaccine must tolerate at least 40 degrees Celsius for a minimum of three days, be licensed for CTC use with that stated on its label, and carry a vaccine vial monitor on each vial and a peak threshold indicator in each carrier.
CTC is a regulated, product-specific approach. It applies only to vaccines licensed for it and is no basis for relaxing storage on other products.
5. Better passive packaging and phase-change materials
Many shipments rely on insulated boxes and refrigerants rather than powered units. Phase-change materials (PCMs) absorb and release heat at a set temperature and are used to hold a payload within range for a defined duration. A 2022 systematic review in Energies describes how modelling and testing studies compare PCM layouts and melting points, and how results depend on where the PCM sits in the box.
For buyers, the point is qualification, not marketing hours. A shipper’s rated duration holds only for the tested configuration, season and route profile. Ask suppliers for validation data that match your lanes.
6. Cryogenic shipping with smart monitoring for cell and gene therapies
Cell and gene therapies often need storage at or below minus 120 to minus 150 degrees Celsius. They travel in liquid-nitrogen dry shippers, which UK industry guidance says typically hold temperature for five to ten days under normal conditions. Hold time depends on the shipper’s orientation and handling: tilting increases nitrogen venting and shortens it.
Two safeguards have become standard practice. Smart monitors report temperature, tilt and location in real time, so a courier can intervene before a product thaws. Chains of identity and custody track the product from collection to patient. The same guidance reports that when 20 new manufacturer-qualified dry shippers of one model were retested with the payload and a data logger fitted, five failed to meet the minimum static hold time. This is a good example of why in-situ validation matters.
7. Data-driven assessment of temperature excursions
Excursions will still happen. The breakthrough here is making better decisions afterwards, instead of discarding everything by default or, worse, releasing doubtful product.
USP’s definition of controlled room temperature (20 to 25 degrees Celsius) allows excursions between 15 and 30 degrees Celsius provided the mean kinetic temperature stays at or below 25 degrees Celsius. Mean kinetic temperature (MKT) is a single calculated figure that represents the cumulative thermal effect of varying temperatures. Separately, a review of room-temperature stability data for 79 refrigerated medicines found wide variation: roughly 23 percent of entries were stable for a day or less, while about 35 percent were stable for 8 to 30 days.
Disposition decisions should rely on manufacturer stability data and quality procedures. The wide range shows why a blanket rule is unsafe and why continuous data logging is the foundation for every other improvement here.
What the evidence does and does not say
Each of these seven areas has support, but the strength differs. The Kenya monitoring study and the Rwanda drone study are published, peer-reviewed field evaluations with measured results. Solar refrigeration, CTC and cryogenic shipping rest on WHO standards, programme data and industry guidance. Packaging and excursion assessment depend on validation for your product and route.
None of these sources supports a single headline figure for loss reduction across the whole pharmaceutical cold chain. Reported gains are specific: 7 percentage points more time in range in the Kenya pilot, and a 67 percent fall in blood-unit expirations in Rwanda. They should not be added together or generalised.
Key takeaways
- Continuous remote monitoring with people acting on the data improved time in range in a Kenyan vaccine pilot.
- Drone delivery cut blood-product wastage by 67 percent at 12 months in Rwanda, but evidence for other products is limited.
- Solar direct-drive refrigerators and the WHO controlled temperature chain extend reach where power or refrigeration is unreliable.
- Packaging, cryogenic shippers and excursion decisions should be validated for your own lanes and products.
- Treat large, uncited loss-reduction percentages with scepticism.
Frequently asked questions
What is the pharmaceutical cold chain?
It is the temperature-controlled chain of storage, transport and handling that keeps medicines such as vaccines, insulin and biologics within their labelled range from manufacture to patient.
What temperature range do most cold chain medicines need?
Many refrigerated products, including most vaccines, are held at 2 to 8 degrees Celsius. Frozen, ultra-low and cryogenic products need much lower temperatures. Always follow the product label.
Can drones deliver temperature-sensitive medicines?
Rwanda’s blood-product programme shows they can in a real, large-scale setting. Evidence for other product types is still developing, and local aviation rules apply.
This article is for general industry information. Storage and handling decisions must follow product labelling, manufacturer instructions and applicable good distribution practice requirements.
Sources
- Nisingizwe MP et al. Effect of unmanned aerial vehicle (drone) delivery on blood product delivery time and wastage in Rwanda. The Lancet Global Health, 2022;10(4):e564-e569: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(22)00048-1/fulltext (abstract also at https://rbc.gov.rw/rnhrr/pub?code=279)
- Using Data to Keep Vaccines Cold in Kenya: Remote Temperature Monitoring with Data Review Teams. Glob Health Sci Pract 2019;7(4):585-597: https://pubmed.ncbi.nlm.nih.gov/31852740
- Temperature Excursions in Cold Chain Management: Assessing the Accuracy of Refrigerator Temperature Probes: https://pmc.ncbi.nlm.nih.gov/articles/PMC11559836
- WHO, Controlled temperature chain (CTC): https://www.who.int/teams/immunization-vaccines-and-biologicals/essential-programme-on-immunization/supply-chain/controlled-temperature-chain-(ctc)
- When are solar refrigerators less costly than on-grid refrigerators (Mozambique simulation): https://ncbi.nlm.nih.gov/pmc/articles/PMC5548121
- Solarized vaccine cold chain in Lebanon: https://pmc.ncbi.nlm.nih.gov/articles/PMC11187096
- Promising and Potential Applications of Phase Change Materials in the Cold Chain: A Systematic Review. Energies 2022;15(20):7683: https://www.mdpi.com/1996-1073/15/20/7683
- ATTC Network (UK), Review and recommendations on cryopreservation of starting materials for ATMPs: https://www.theattcnetwork.co.uk/wp-content/uploads/2022/03/UK-review-and-recommendations-on-cryopreservation-of-starting-materials-for-ATMPs.pdf
- ATTC Network, Tracking and storage considerations (dry shipper hold-time test): https://www.theattcnetwork.co.uk/wp-content/uploads/2021/11/DL175_Tracking-and-storage-considerations-to-maintain-parameters-during-shipping-and-storage-for-different-products.pdf
- Mean kinetic temperature evaluations through simulated temperature excursions. BMC Public Health 2022: https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-022-12660-9
- Stability of Refrigerated Medications at Room Temperature (Cohen et al. data): https://ncbi.nlm.nih.gov/pmc/articles/PMC12465357
- 2019 Biopharma Cold Chain Logistics Survey (Peli BioThermal; cites IQVIA $35B estimate): https://cdn2.hubspot.net/hubfs/4107558/general%20content/PEL1046_SurveyReport_v4a.pdf ; also Air Cargo News summary: https://www.aircargonews.net/pharma-logistics/2019/07/failures-in-temperature-controlled-logistics-cost-biopharma-industry-billions/
- PMC9253487 (cites WHO 2005 wastage figure): https://pmc.ncbi.nlm.nih.gov/articles/PMC9253487